The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury

Seltzer, Z., Dubner, R., & Shir, Y. (1990) · Pain · doi:10.1016/0304-3959(90)91074-s · Cited by 1,847 · see citing works

The orphan receptor GPR55 is a novel cannabinoid receptor

Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568 · see citing works

A method for measurement of analgesic activity on inflamed tissue.

Randall, L. O., & Selitto, J. J. (1957) · PubMed · Cited by 1,568 · see citing works

Pharmacology of cannabinoid CB1 and CB2 receptors

Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,489 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,065 · see citing works

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current

Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 710 · see citing works

Pharmacological Actions of Cannabinoids

Pertwee, R. G. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_1 · Cited by 600 · see citing works

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors

Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1916 · Cited by 571 · see citing works

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor

Buckley, N. E., McCoy, K. L., Mezey, É., Bonner, T. I., Zimmer, A. M., Felder, C. C., Glass, M., & Zimmer, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00211-9 · Cited by 544 · see citing works

Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?

Verri, W. A., Jr., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 538 · see citing works

CB ₂ cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids

Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

Identification of GPR55 as a lysophosphatidylinositol receptor

Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.078 · Cited by 460 · see citing works

Novel cannabinoid receptors

Brown, A. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707481 · Cited by 410 · see citing works

Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains

Markel, P. D., Shu, P., Ebeling, C., Carlson, G. A., Nagle, D. L., Smutko, J. S., & Moore, K. J. (1997) · Nature Genetics · doi:10.1038/ng1197-280 · Cited by 401 · see citing works

Evidence for novel cannabinoid receptors

Begg, M., Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Mo, F.-M., LIU, J., & Kunos, G. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.11.005 · Cited by 385 · see citing works

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, ΨGPR53 and GPR55: GPR55 is extensively expressed in human brain

Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H., George, S. R., & O’Dowd, B. F. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00277-0 · Cited by 378 · see citing works

In silico patent searching reveals a new cannabinoid receptor

Baker, D., Pryce, G., Davies, W. I. L., & Hiley, C. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.11.003 · Cited by 347 · see citing works

Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study

Núñez, E., Benito, C., Pazos, M. R., Barbáchano, A., Fajardo, O., González, S. R., Tolón, R. M., & Romero, J. (2004) · Synapse · doi:10.1002/syn.20050 · Cited by 334 · see citing works

Speed congenics: a classic technique in the fast lane (relatively speaking)

Wakeland, E. K., Morel, L. M., Achey, K., Yui, M. A., & Longmate, J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01126-2 · Cited by 333 · see citing works

Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy

Valenzano, K. J., Tafesse, L., Lee, G., Harrison, J. E., Boulet, J. M., Gottshall, S. L., Mark, L., Pearson, M. S., Miller, W., Shan, S., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.008 · Cited by 288 · see citing works

Cannabinoid receptors and endocannabinoids: Evidence for new players

Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275 · see citing works

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

Clayton, N., Marshall, F. H., Bountra, C., & O'Shaughnessy, C. T. (2002) · Pain · doi:10.1016/s0304-3959(01)00454-7 · Cited by 247 · see citing works

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

Quartilho, A., Mata, H. P., Ibrahim, M. M., Vanderah, T. W., Porreca, F., Makriyannis, A., & Malan, T. P. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00031 · Cited by 243 · see citing works

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

Johns, D. G., Behm, D. J., Walker, D. J., Zhang, A., Shapland, E. M., Daniels, D. A., Riddick, M., Dowell, S. J., Staton, P. C., Green, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707419 · Cited by 242 · see citing works

Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor

Offertáler, L., Mo, F.-M., Bátkai, S., Liu, J., Begg, M., Razdan, R. K., Martin, B. R., Bukoski, R. D., & Kunos, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.699 · Cited by 227 · see citing works

CB2 cannabinoid receptor mediation of antinociception

Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J. Y., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, P. T. (2006) · Pain · doi:10.1016/j.pain.2005.12.018 · Cited by 172 · see citing works

Antinociceptive Effects of Interleukin-4, -10, and -13 on the Writhing Response in Mice and Zymosan-Induced Knee Joint Incapacitation in Rats

Vale, M. L., Marques, J. B., Moreira, C. A., Rocha, F. A. C., Ferreira, S. H., Poole, S., Cunha, F. Q., & Ribeiro, R. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038703 · Cited by 152 · see citing works

Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

Hohmann, A. G., Farthing, J. N., Zvonok, A. M., & Makriyannis, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060079 · Cited by 123 · see citing works

Development of SHIRPA to characterise the phenotype of gene-targeted mice

Hatcher, J. P., Jones, D. N. C., Rogers, D. C., Hatcher, P. D., Reavill, C., Hagan, J. J., & Hunter, A. J. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00275-3 · Cited by 100 · see citing works

Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat

Elmes, S. J. R., Winyard, L. A., Medhurst, S. J., Clayton, N. M., Wilson, A. W., Kendall, D. A., & Chapman, V. (2005) · Pain · doi:10.1016/j.pain.2005.09.005 · Cited by 97 · see citing works

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833

Whiteside, G. T., Gottshall, S. L., Boulet, J. M., Chaffer, S. M., Harrison, J., Pearson, M. S., Turchin, P. I., Mark, L., Garrison, A. E., & Valenzano, K. J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.043 · Cited by 94 · see citing works

The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling

Kleinschnitz, C., Brinkhoff, J., Zelenka, M., Sommer, C., & Stoll, G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.12.013 · Cited by 90 · see citing works

Bradykinin B1 and B2 receptors, tumour necrosis factor α and inflammatory hyperalgesia

Poole, S., Lorenzetti, B. B., da Cunha, J. M., Cunha, F. Q., & Ferreira, S. H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702347 · Cited by 85 · see citing works

Interferon-γ receptors in nociceptive pathways

Robertson, B., Xu, X., Hao, J., Wiesenfeld‐Hallin, Z., Mhlanga, J., Grant, G., & Kristensson, K. (1997) · Neuroreport · doi:10.1097/00001756-199703240-00050 · Cited by 84 · see citing works

Cannabinoid CB2 receptor agonist activity in the hindpaw incision

LaBuda, C. J., Koblish, M., & Little, P. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.020 · Cited by 76 · see citing works

Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice

Kanaan, S. A., Poole, S., Saadé, N. E., Jabbur, S. J., & Safieh‐Garabedian, B. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00027-7 · Cited by 69 · see citing works

GPR55 as a New Cannabinoid Receptor: Still a Long Way to Prove It

Petitet, F., DONLAN, M. E., & Michel, A. G. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00370.x · Cited by 65 · see citing works

Therapeutic potential of cannabinoid receptor agonists as analgesic agents

Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60 · see citing works

Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein

George, A., Kleinschnitz, C., Zelenka, M., Brinkhoff, J., Stoll, G., & Sommer, C. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.011 · Cited by 51 · see citing works

Determination of changes in mRNA expression in a rat model of neuropathic pain by Taqman™ quantitative RT-PCR

MacDonald, R. E., Bingham, S., Bond, B. C., Parsons, A. A., & Philpott, K. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00086-9 · Cited by 47 · see citing works

Increased responsiveness of rat dorsal horn neurons in vivo following prolonged intrathecal exposure to interferon-γ

Vikman, K. S., Siddall, P. J., & Duggan, A. W. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.059 · Cited by 38 · see citing works

CB2 cannabinoid receptor mediation of antinociception

Ibrahim, M. M., Rude, M. L., Stagg, N. J., Mata, H. P., Lai, J., Vanderah, T. W., Porreca, F., Buckley, N. E., Makriyannis, A., & Malan, T. P. (2006) · Acute Pain · doi:10.1016/j.acpain.2006.08.026 · Cited by 4 · see citing works

Antioxidative and Anti-Inflammatory Properties of Cannabidiol

Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 839 · see citing works

Molecular Targets of Cannabidiol in Neurological Disorders

Bih, C. I., Chen, T., Nunn, A. V. W., Bazelot, M., Dallas, M. L., & Whalley, B. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0377-3 · Cited by 582 · see citing works

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476 · see citing works

Cannabinoids and Pain: New Insights From Old Molecules

Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 417 · see citing works

Emerging roles of lysophospholipids in health and disease

Tan, S. T., Ramesh, T., Toh, X. R., & Nguyen, L. N. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101068 · Cited by 372 · see citing works

Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists

Pertwee, R. G. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980050 · Cited by 335 · see citing works

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

Whyte, L. S., Ryberg, E., Sims, N. A., Ridge, S. A., Mackie, K., Greasley, P. J., Ross, R. A., & Rogers, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902743106 · Cited by 331 · see citing works

Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay

Yin, H., Chu, A., Li, W., Wang, B., Shelton, F., Otero, F. J., Nguyen, D. G., Caldwell, J. S., & Chen, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806516200 · Cited by 313 · see citing works

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside

Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305 · see citing works

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303 · see citing works

Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis

Hammell, D. C., Zhang, L., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2015) · European Journal of Pain · doi:10.1002/ejp.818 · Cited by 307 · see citing works

The enigmatic pharmacology of GPR55

Ross, R. A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.12.004 · Cited by 295 · see citing works

The GPR55 ligand L‐α‐lysophosphatidylinositol promotes RhoA‐dependent Ca 2+ signaling and NFAT activation

Henstridge, C. M., Balenga, N. A. B., Ford, L., Ross, R. A., Waldhoer, M., & Irving, A. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-108670 · Cited by 285 · see citing works

Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues

Delacher, M., Imbusch, C. D., Weichenhan, D., Breiling, A., Hotz-Wagenblatt, A., Träger, U., Hofer, A.-C., Kägebein, D., Wang, Q., Frauhammer, F., et al. (2017) · Nature Immunology · doi:10.1038/ni.3799 · Cited by 282 · see citing works

Cannabinoids and Epilepsy

Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 282 · see citing works

Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands

Kapur, A., Zhao, P., Sharir, H., Bai, Y., Caron, M. G., Barak, L. S., & Abood, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050187 · Cited by 275 · see citing works

Receptors for acylethanolamides—GPR55 and GPR119

Godlewski, G., Offertáler, L., Wagner, J. A., & Kunos, G. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.07.001 · Cited by 235 · see citing works

Pharmacological characterization of GPR55, a putative cannabinoid receptor

Sharir, H., & Abood, M. E. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.004 · Cited by 234 · see citing works

The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation

Piñeiro, R., Maffucci, T., & Falasca, M. (2010) · Oncogene · doi:10.1038/onc.2010.417 · Cited by 218 · see citing works

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 217 · see citing works

Cytokines in Pain: Harnessing Endogenous Anti-Inflammatory Signaling for Improved Pain Management

Vanderwall, A. G., & Milligan, E. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03009 · Cited by 219 · see citing works

Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels

PETROCELLIS, L. D., & Marzo, V. D. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9177-z · Cited by 216 · see citing works

GPR55 ligands promote receptor coupling to multiple signalling pathways

Henstridge, C. M., Balenga, N. A. B., Schröder, R. J., Kargl, J., Platzer, W., Martini, L., Arthur, J. S. C., Penman, J., Whistler, J. L., Kostenis, E., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00625.x · Cited by 209 · see citing works

Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal

Deng, L., Guindon, J., Cornett, B., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.009 · Cited by 200 · see citing works

Cannabinoids and Pain: Sites and Mechanisms of Action

Starowicz, K., & Finn, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 192 · see citing works

The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK

Andradas, C., Caffarel, M. M., Pérez-Gómez, E., Salazar‐Roa, M., Lorente, M., Velasco, G., Guzmán, M., & Sánchez, C. (2010) · Oncogene · doi:10.1038/onc.2010.402 · Cited by 183 · see citing works

An Update on Non-CB 1 , Non-CB 2 Cannabinoid Related G-Protein-Coupled Receptors

Morales, P., & Reggio, P. H. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0036 · Cited by 168 · see citing works

Novel lysophosphoplipid receptors: their structure and function

Makide, K., Uwamizu, A., Shinjo, Y., Ishiguro, J., Okutani, M., Inoue, A., & Aoki, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046920 · Cited by 162 · see citing works

The l -α-Lysophosphatidylinositol/ GPR55 System and Its Potential Role in Human Obesity

Moreno‐Navarrete, J. M., Catalán, V., Whyte, L. S., Díaz–Arteaga, A., Vázquez‐Martínez, R., Rotellar, F., Guzmán‐Ruiz, R., Gómez‐Ambrosi, J., Pulido, M. R., Russell, W. R., et al. (2011) · Diabetes · doi:10.2337/db11-0649 · Cited by 160 · see citing works

Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

Henstridge, C. M., Balenga, N. A. B., Kargl, J., Andradas, C., Brown, A. J., Irving, A. J., Sánchez, C., & Waldhoer, M. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1197 · Cited by 159 · see citing works

Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids

Anavi‐Goffer, S., Baillie, G. L., Irving, A. J., Gertsch, J., Greig, I. R., Pertwee, R. G., & Ross, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.296020 · Cited by 151 · see citing works

Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?

Kunos, G., Osei‐Hyiaman, D., Bátkai, S., Sharkey, K. A., & Makriyannis, A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.10.001 · Cited by 137 · see citing works

Advances in the Physiology of GPR55 in the Central Nervous System

Marichal‐Cancino, B. A., Fajardo-Valdez, A., Ruiz‐Contreras, A. E., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160729155441 · Cited by 133 · see citing works

Differential changes in GPR55 during microglial cell activation

Pietr, M., Kozela, E., Levy, R., Rimmerman, N., Lin, Y. H., Stella, N., Vogel, Z., & Juknat, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.028 · Cited by 130 · see citing works

Heteromerization of GPR 55 and cannabinoid CB 2receptors modulates signalling

Balenga, N. A. B., Martínez‐Pinilla, E., Kargl, J., Schröder, R. J., Peinhaupt, M., Platzer, W., Bálint, Z., Zamarbide, M., Dopeso‐Reyes, I. G., Ricobaraza, A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12850 · Cited by 128 · see citing works

Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord

Guy, A. T., Nagatsuka, Y., Ooashi, N., Inoue, M., Nakata, A., Greimel, P., Inoue, A., Nabetani, T., Murayama, A., Ohta, K., et al. (2015) · Science · doi:10.1126/science.aab3516 · Cited by 121 · see citing works

A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans

Romero‐Zerbo, S., Rafacho, A., Díaz–Arteaga, A., Suárez, J., Quesada, I., Imbernón, M., Ross, R. A., Diéguez, C., de Fonseca, F. R., Nogueiras, R., et al. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0166 · Cited by 119 · see citing works

Current evidence of cannabinoid‐based analgesia obtained in preclinical and human experimental settings

Lötsch, J., Weyer-Menkhoff, I., & Tegeder, I. (2017) · European Journal of Pain · doi:10.1002/ejp.1148 · Cited by 118 · see citing works

GPR55 – a putative “type 3” cannabinoid receptor in inflammation

Yang, H.-W., Zhou, J., & Lehmann, C. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0080 · Cited by 117 · see citing works

Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures

Małek, N., Popiołek-Barczyk, K., Mika, J., Przewłocka, B., & Starowicz, K. (2015) · Neural Plasticity · doi:10.1155/2015/130639 · Cited by 114 · see citing works

What we know and do not know about the cannabinoid receptor 2 (CB2)

Malfitano, A. M., Basu, S., Maresz, K., Bifulco, M., & Dittel, B. N. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.002 · Cited by 112 · see citing works

GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination

Wu, C., Chen, H., Sun, H., Zhu, J., Jew, C. P., Wager‐Miller, J., Straiker, A. J., Spencer, C. M., Bradshaw, H. B., Mackie, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060314 · Cited by 112 · see citing works

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses

Breijyeh, Z., Jubeh, B., Bufo, S. A., Karaman, R., & Scrano, L. (2021) · Toxins · doi:10.3390/toxins13020117 · Cited by 120 · see citing works

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

Schicho, R., Bashashati, M., Bawa, M., McHugh, D., Saur, D., Hu, H., Zimmer, A., Lutz, B., Mackie, K., Bradshaw, H. B., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21538 · Cited by 109 · see citing works

GPR55: A therapeutic target for Parkinson's disease?

Celorrio, M., Rojo-Bustamante, E., Fernández‐Suárez, D., Sáez, E., de Mendoza, A. E., Müller, C. E., Ramírez, M. J., Oyarzábal, J., Franco, R., & Aymerich, M. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.017 · Cited by 106 · see citing works

Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands

Alhouayek, M., Masquelier, J., & Muccioli, G. G. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.011 · Cited by 106 · see citing works

The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility

Karasu, T., Marczylo, T. H., Maccarrone, M., & Konje, J. C. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq058 · Cited by 103 · see citing works

Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands

Kotsikorou, E., Sharir, H., Shore, D. M., Hurst, D. P., Lynch, D. L., Madrigal, K. E., Heynen‐Genel, S., Milan, L. B., Chung, T. D. Y., Seltzman, H. H., et al. (2013) · Biochemistry · doi:10.1021/bi4008885 · Cited by 102 · see citing works

Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells

Oka, S., Kimura, S., Toshida, T., Ota, R., Yamashita, A., & Sugiura, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvp208 · Cited by 101 · see citing works

The GPR 55 antagonist CID 16020046 protects against intestinal inflammation

Stančić, A., Jandl, K., Hasenoehrl, C., Reichmann, F., Marsche, G., Schuligoi, R., Heinemann, Á., Storr, M., & Schicho, R. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12639 · Cited by 99 · see citing works

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

Abate, G., Uberti, D. L., & Tambaro, S. (2021) · Biology · doi:10.3390/biology10060542 · Cited by 101 · see citing works

Lysophosphatidylinositol signalling: New wine from an old bottle

Piñeiro, R., & Falasca, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.01.009 · Cited by 99 · see citing works

The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells

Chiurchiù, V., Lanuti, M., Bardi, M. D., Battistini, L., & Maccarrone, M. (2014) · International Immunology · doi:10.1093/intimm/dxu097 · Cited by 99 · see citing works

A Selective Antagonist Reveals a Potential Role of G Protein–Coupled Receptor 55 in Platelet and Endothelial Cell Function

Kargl, J., Brown, A. J., Andersen, L., Dorn, G., Schicho, R., Waldhoer, M., & Heinemann, Á. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.204180 · Cited by 98 · see citing works

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55

Alba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 94 · see citing works

The Cannabinoid Receptor CB1 Modulates the Signaling Properties of the Lysophosphatidylinositol Receptor GPR55

Kargl, J., Balenga, N. A. B., Parzmair, G. P., Brown, A. J., Heinemann, Á., & Waldhoer, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364109 · Cited by 96 · see citing works

The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55

Sharir, H., Console‐Bram, L., Mundy, C., Popoff, S. N., Kapur, A., & Abood, M. E. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9351-6 · Cited by 96 · see citing works

GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis

Kargl, J., Andersen, L., Hasenoehrl, C., Feuersinger, D., Stančić, A., Fauland, A., Magnes, C., Heliebi, A. E., Lax, S., Uranitsch, S., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13345 · Cited by 96 · see citing works

A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents

Lin, X. ‐., Yuece, B., Li, Y. ‐., Feng, Y., Feng, J. ‐., Yu, L. ‐., Li, K., Li, Y.-X., & Storr, M. (2011) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2011.01742.x · Cited by 94 · see citing works

Cannabinoid system in the skin – a possible target for future therapies in dermatology

Kupczyk, P., Reich, A., & Szepietowski, J. C. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00923.x · Cited by 93 · see citing works

The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas

Pérez-Gómez, E., Andradas, C., Flores, J. M., Quintanilla, M., Paramio, J. M., Guzmán, M., & Sánchez, C. (2012) · Oncogene · doi:10.1038/onc.2012.278 · Cited by 94 · see citing works

Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

Karst, M., Wippermann, S., & Ahrens, J. (2010) · Drugs · doi:10.2165/11585260-000000000-00000 · Cited by 91 · see citing works

The Role of the Brain's Endocannabinoid System in Pain and Its Modulation by Stress

Corcoran, L., Roche, M., & Finn, D. P. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.003 · Cited by 86 · see citing works

A molecular basis for the anti‐inflammatory and anti‐fibrosis properties of cannabidiol

Sunda, F., & Arowolo, A. (2020) · The FASEB Journal · doi:10.1096/fj.202000975r · Cited by 84 · see citing works

Lysophosphatidylinositol Signalling and Metabolic Diseases

Arifin, S. A., & Falasca, M. (2016) · Metabolites · doi:10.3390/metabo6010006 · Cited by 85 · see citing works

Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells

Saliba, S. W., Jauch, H., Gargouri, B., Keil, A., Hurrle, T., Volz, N., Mohr, F., van der Stelt, M., Bräse, S., & Fiebich, B. L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1362-7 · Cited by 86 · see citing works

GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage

Sumida, H., Lu, E., Chen, H., Yang, Q., Mackie, K., & Cyster, J. G. (2017) · Science Immunology · doi:10.1126/sciimmunol.aao1135 · Cited by 80 · see citing works

The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55

Yamashita, A., Oka, S., Tanikawa, T., Hayashi, Y., Nemoto‐Sasaki, Y., & Sugiura, T. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.05.004 · Cited by 78 · see citing works

Identification of the GPR55 Agonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands

Kotsikorou, E., Madrigal, K. E., Hurst, D. P., Sharir, H., Lynch, D. L., Heynen‐Genel, S., Milan, L. B., Chung, T. D. Y., Seltzman, H. H., Bai, Y., et al. (2011) · Biochemistry · doi:10.1021/bi200010k · Cited by 79 · see citing works

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 79 · see citing works

Involvement of the opioid and cannabinoid systems in pain control: New insights from knockout studies

Nadal, X., La Porta, C., Andreea Bura, S., & Maldonado, R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.077 · Cited by 76 · see citing works

Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review

Hryhorowicz, S., Kaczmarek-Ryś, M., Zielińska, A., Scott, R. J., Słomski, R., & Pławski, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.790803 · Cited by 76 · see citing works

Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice

Rahimi, A., Faizi, M., Talebi, F., Noorbakhsh, F., Kahrizi, F., & Naderi, N. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.030 · Cited by 78 · see citing works

The therapeutic potential of novel cannabinoid receptors

Kreitzer, F. R., & Stella, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.01.005 · Cited by 74 · see citing works

Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors

Irving, A. J., Abdulrazzaq, G., Chan, S., Penman, J., Harvey, J., & Alexander, S. P. H. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.04.004 · Cited by 73 · see citing works

Pharmacology of GPR55 in Yeast and Identification of GSK494581A as a Mixed-Activity Glycine Transporter Subtype 1 Inhibitor and GPR55 Agonist

Brown, A. J., Daniels, D. A., Kassim, M., Brown, S. A., Haslam, C. P., Terrell, V. R., Brown, J. D., Nichols, P. L., Staton, P. C., Wise, A., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.172650 · Cited by 73 · see citing works

Phytocannabinoid Pharmacology: Medicinal Properties of Cannabis sativa Constituents Aside from the “Big Two”

Sampson, P. B. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00965 · Cited by 72 · see citing works

Phospholipases of Mineralization Competent Cells and Matrix Vesicles: Roles in Physiological and Pathological Mineralizations

Mebarek, S., Abousalham, A., Magne, D., Do, L.-D., Bandorowicz‐Pikuła, J., Pikuła, S., & Buchet, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035036 · Cited by 69 · see citing works

L-α-Lysophosphatidylinositol meets GPR55: a deadly relationship

Ross, R. A. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.01.005 · Cited by 67 · see citing works

Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation

Hill, J. D., Zuluaga‐Ramirez, V., Gajghate, S., Winfield, M., Sriram, U., Rom, S., & Persidsky, Y. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.11.017 · Cited by 66 · see citing works

A potential role for GPR55 in gastrointestinal functions

Schicho, R., & Storr, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.009 · Cited by 65 · see citing works

The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55

Schuelert, N., & McDougall, J. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.06.004 · Cited by 65 · see citing works

Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

García‐Gutiérrez, M. S., Navarrete, F., Navarro, G., Reyes‐Resina, I., Franco, R., Lanciego, J. L., Giner, S., & Manzanares, J. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0610-y · Cited by 65 · see citing works

Roles of G protein-coupled receptors in inflammatory bowel disease

Zeng, Z., Mukherjee, A., Varghese, A. P., Xiao-li, Y., Chen, S., & Zhang, H. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i12.1242 · Cited by 62 · see citing works

NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System

Vanegas, H., Vázquez, E., & Tortorici, V. (2010) · Pharmaceuticals · doi:10.3390/ph3051335 · Cited by 62 · see citing works

GPR55: a new promising target for metabolism?

Tudurí, E., Imbernón, M., Hernández-Bautista, R., Tojo, M., Fernø, J., Diéguez, C., & Nogueiras, R. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0253 · Cited by 62 · see citing works

GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide

Im, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031034 · Cited by 60 · see citing works

Off-Target Cannabinoid Effects Mediated by GPR55

Henstridge, C. M. (2012) · Pharmacology · doi:10.1159/000336872 · Cited by 60 · see citing works

The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress

Shi, Q., Yang, L.-K., Shi, W., Wang, L., Zhou, S., Guan, S., Zhao, M., & Yang, Q. (2017) · Molecular Brain · doi:10.1186/s13041-017-0318-7 · Cited by 61 · see citing works

GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors

Zhao, P., & Abood, M. E. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.039 · Cited by 59 · see citing works

A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity

Hurst, K., Badgley, C., Ellsworth, T. S., Bell, S., Friend, L. N., Prince, B., Welch, J., Cowan, Z., Williamson, R., Lyon, C., et al. (2017) · Hippocampus · doi:10.1002/hipo.22747 · Cited by 57 · see citing works

Nicotinic acetylcholine receptors modulate osteoclastogenesis

Mandl, P., Hayer, S., Karonitsch, T., Scholze, P., Győri, D., Sykoutri, D., Blüml, S., Mócsai, A., Poór, G., Huck, S., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0961-x · Cited by 54 · see citing works

GPCRs involved in metabolic diseases: pharmacotherapeutic development updates

Jin, C., Chen, H., Xie, L. H., Zhou, Y., Liu, L., & Wu, J. H. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01215-2 · Cited by 52 · see citing works

The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray

Deliu, E., Sperow, M., Console‐Bram, L., Carter, R. L., Tilley, D. G., Kalamarides, D. J., Kirby, L. G., Brailoiu, G. C., Brailoiu, E., Benamar, K., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099333 · Cited by 52 · see citing works

Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB1/CB2 versus GPR55 receptors

Wang, X., Galaj, E., Bi, G., Zhang, C., He, Y., Zhan, J., Bauman, M. H., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14958 · Cited by 50 · see citing works

The putative cannabinoid receptor GPR55 promotes cancer cell proliferation

Hu, G., Ren, G., & Shi, Y. (2010) · Oncogene · doi:10.1038/onc.2010.502 · Cited by 49 · see citing works

G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis

Moran, B. M., Flatt, P. R., & McKillop, A. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-015-0826-9 · Cited by 49 · see citing works

Cannabinoids in the descending pain modulatory circuit: Role in inflammation

Bouchet, C. A., & Ingram, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107495 · Cited by 51 · see citing works

Mode of action of cannabinoids on nociceptive nerve endings

Kress, M., & Kuner, R. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1762-0 · Cited by 49 · see citing works

Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages

Lanuti, M., Talamonti, E., Maccarrone, M., & Chiurchiù, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126839 · Cited by 45 · see citing works

Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice

Carey, L. M., Gutierrez, T., Deng, L., Lee, W.-H., Mackie, K., & Hohmann, A. G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01062-2 · Cited by 35 · see citing works

GPR55 contributes to neutrophil recruitment and mechanical pain induction after spinal cord compression in mice

Ono, T., Yamashita, T., Kano, R., Inoue, M., Okada, S., Kano, K., Koizumi, S., Iwabuchi, K., Hirabayashi, Y., Matsuo, I., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.008 · Cited by 13 · see citing works

Contribution of G Protein-Coupled Receptor 55 to Periaqueductal Gray-Mediated Antinociception in the Inflammatory Pain

Blanton, H. L., Armin, S., Muenster, S., Abood, M. E., & Benamar, K. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0006 · Cited by 11 · see citing works

GPR55 and GPR119 Receptors Contribute to the Processing of Neuropathic Pain in Rats

Zúñiga‐Romero, Á., Rivera-Plata, Q., Arrieta, J., Flores‐Murrieta, F. J., Rodríguez‐Silverio, J., Reyes-García, J. G., Huerta‐Cruz, J. C., Ramírez-Martínez, G., & Rocha-­González, H. I. (2022) · Pharmaceuticals · doi:10.3390/ph15010067 · Cited by 11 · see citing works

Dissecting the role of GPR55 agonist lysophosphatidylinositol in mechanically evoked pain

Škoricová, D. (2011) · Digital Repository (National Repository of Grey Literature)